PPIDT00409
Drug Information
| Name | Motixafortide |
|---|---|
| Sequence | RRXCYXKKPYRXCR |
| DrugBank_ID | DB14939 |
| Type | biotech |
| Indication | Motixafortide is indicated for use in combination with [filgrastim] to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with multiple myeloma.[L48116] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, powder, lyophilized, for solution | Subcutaneous |
62 mg/1.7mL
|